Sabine M J Straus
Overview
Explore the profile of Sabine M J Straus including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
44
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mazzaglia G, Straus S, Arlett P, da Silva D, Janssen H, Raine J, et al.
Drug Saf
. 2017 Nov;
41(2):191-202.
PMID: 29124666
Introduction: Studies measuring the effectiveness of risk minimization measures (RMMs) submitted by pharmaceutical companies to the European Medicines Agency are part of the post-authorization regulatory requirements and represent an important...
2.
Mol P, Arnardottir A, Straus S, de Graeff P, Haaijer-Ruskamp F, Quik E, et al.
Br J Clin Pharmacol
. 2014 Dec;
79(6):978-87.
PMID: 25469876
Aims: To compare the values regulators attach to different drug effects of oral antidiabetic drugs with those of doctors and patients. Methods: We administered a 'discrete choice' survey to regulators,...
3.
Arnardottir A, Haaijer-Ruskamp F, Straus S, de Graeff P, Mol P
Drug Saf
. 2011 Oct;
34(11):1101-14.
PMID: 21981437
Background: Knowledge on the safety of new medicines is limited at the time of market entry. Nearly half of all drugs used to treat HIV registered in the EU required...
4.
Arnardottir A, Haaijer-Ruskamp F, Straus S, Eichler H, de Graeff P, Mol P
Br J Clin Pharmacol
. 2011 Apr;
72(3):490-9.
PMID: 21501215
Aims: Regulatory requirements for new drugs have increased. Special approval procedures with priority assessment are possible for drugs with clear 'unmet medical need'. We question whether these Exceptional Circumstances (EC)...